PHARMAKNOWLEDGE ApS: Financial statements 2025
CVR: 30523202
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PHARMAKNOWLEDGE ApS (CVR 30523202) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,254 and a net result of DKK 20,016 compared with DKK 47,554 the year before. Equity in the 2025 report amounted to DKK 545,996. The solvency ratio was 98.3%.
- Gross Profit
- DKK -5,254
- Profit/Loss
- DKK 20,016
- Equity
- DKK 545,996
- Total Assets
- DKK 555,426
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -5K | 20K | 546K | - |
| 2024 | - | -5K | 48K | 526K | - |
| 2023 | - | -5K | 38K | 478K | - |
| 2022 | - | -4K | -61K | 441K | - |
| 2021 | - | 23K | 56K | 502K | - |
Official annual report
How creditworthy is PHARMAKNOWLEDGE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PHARMAKNOWLEDGE ApS has published its annual report for 2024. Gross profit came to DKK -5,161, and the net result was DKK 47,554.
About PHARMAKNOWLEDGE ApS
PHARMAKNOWLEDGE ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2008. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Lene Worsaae Dalby. The company is owned by Lene Worsaae Dalby. The company has 1 employee (2011). In 2025, the company reported a gross profit of DKK -5,254 and a net result of DKK 20,016 compared with DKK 47,554 the year before. Equity in the 2025 report amounted to DKK 545,996.